News & Updates

Bempedoic acid improves lipid, glycaemic parameters regardless of metabolic status

22 Nov 2021 by

Data presented at AHA 2021 demonstrated the efficacy and safety of bempedoic acid for improving lipid and glycaemic parameters and hsCRP irrespective of metabolic status.

Bempedoic acid improves lipid, glycaemic parameters regardless of metabolic status

22 Nov 2021

Mangoes a healthier alternative to processed snack foods for overweight, obese adults

21 Nov 2021

Eating fresh mangoes can help with certain risk factors associated with overweight and obesity, including lower inflammation and better glycaemic control, a study has found.

Mangoes a healthier alternative to processed snack foods for overweight, obese adults

21 Nov 2021

Vitamin D deficiency tied to arterial stiffness in T2DM

21 Nov 2021

Low levels of 25-hydroxyvitamin D seem to be correlated with arterial stiffness in patients with type 2 diabetes mellitus (T2DM), a recent study has found.

Vitamin D deficiency tied to arterial stiffness in T2DM

21 Nov 2021

Iodine fortification may hurt longevity for some older adults

20 Nov 2021

Iodine fortification appears to contribute to increased mortality risk among older adults with a history of hyperthyroidism and moderate iodine deficiency, as reported in a recent study.

Iodine fortification may hurt longevity for some older adults

20 Nov 2021

Energy-restricted Mediterranean diet plus physical activity improves HDL function

19 Nov 2021

An energy-restricted Mediterranean diet combined with physical activity (PA) results in better high-density lipoprotein (HDL) triglyceride metabolism compared with a nonrestrictive diet without PA in older adults with metabolic syndrome (MetS), reports a study.

Energy-restricted Mediterranean diet plus physical activity improves HDL function

19 Nov 2021

Resveratrol supplements confer minimal benefits in T2D, MetS, NAFLD

18 Nov 2021

Supplementation with resveratrol does not appear to provide much benefit in the management of cardiometabolic risk factors in patients with type 2 diabetes (T2D), metabolic syndrome (MetS), and nonalcoholic fatty liver disease (NAFLD), suggests a study.

Resveratrol supplements confer minimal benefits in T2D, MetS, NAFLD

18 Nov 2021

EMPEROR-Preserved: The first successful trial to improve outcomes in HFpEF

18 Nov 2021

Heart failure with preserved ejection fraction (HFpEF) represents a significant unmet medical need. The EMPEROR-Preserved trial aimed to assess the impact of empagliflozin on cardiovascular outcomes in patients with HFpEF. On 27 August 2021, during the hotline session of the 2021 ESC Virtual Congress, the main results of the EMPEROR-Preserved trial were presented by Professor Stefan Anker, principal investigator of the study, and heart failure specialist at Charité Berlin, Germany.

EMPEROR-Preserved: The first successful trial to improve outcomes in HFpEF

18 Nov 2021

Dapagliflozin in COVID-19: Outcomes consistent regardless of kidney status

17 Nov 2021 by

Secondary analysis of the DARE-19* trial presented at ASN Kidney Week 2021 has shown that the effect of dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19 is consistent regardless of kidney disease status.

Dapagliflozin in COVID-19: Outcomes consistent regardless of kidney status

17 Nov 2021

Insulin hypersecretion, not resistance, tied to arterial stiffness in young adults

17 Nov 2021

Postloading insulinaemia appears to be linked to arterial stiffness in young individuals, a recent Japan study has found. In contrast, insulin sensitivity (SI) shows no such effect.

Insulin hypersecretion, not resistance, tied to arterial stiffness in young adults

17 Nov 2021

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes

16 Nov 2021 by

A study by the University of Hong Kong (HKU) has revealed a causal link between better lung function and reduced risk of coronary artery disease (CAD), stroke and type 2 diabetes mellitus (T2DM).

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes

16 Nov 2021

News & Updates

Filter by Specialty:

Specialty:

Bempedoic acid improves lipid, glycaemic parameters regardless of metabolic status

Bempedoic acid improves lipid, glycaemic parameters regardless of metabolic status

Mangoes a healthier alternative to processed snack foods for overweight, obese adults

Mangoes a healthier alternative to processed snack foods for overweight, obese adults

Vitamin D deficiency tied to arterial stiffness in T2DM

Vitamin D deficiency tied to arterial stiffness in T2DM

Iodine fortification may hurt longevity for some older adults

Iodine fortification may hurt longevity for some older adults

Energy-restricted Mediterranean diet plus physical activity improves HDL function

Energy-restricted Mediterranean diet plus physical activity improves HDL function

Resveratrol supplements confer minimal benefits in T2D, MetS, NAFLD

Resveratrol supplements confer minimal benefits in T2D, MetS, NAFLD

EMPEROR-Preserved: The first successful trial to improve outcomes in HFpEF

EMPEROR-Preserved: The first successful trial to improve outcomes in HFpEF

Dapagliflozin in COVID-19: Outcomes consistent regardless of kidney status

Dapagliflozin in COVID-19: Outcomes consistent regardless of kidney status

Insulin hypersecretion, not resistance, tied to arterial stiffness in young adults

Insulin hypersecretion, not resistance, tied to arterial stiffness in young adults

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes